 |
 |
December
22, 2004 |
 |
|
 |
Volume
V, Issue 125 |
 |
|
Home Page : www.otcjournal.com
Email Questions or Comments To:
editor@otcjournal.com
To
OTC Journal Members:
 |
NeWave Corp
(OTC BB: NWAV)- Should See New Wave Of High Prices Next Year |
|
NeWave was without a doubt
one of the best fundamental growth stories the OTC Journal covered
in 2004. The company, through its turn key solution for putting individuals
in business on the internet, found a sweet spot for those looking for help.
From a dead start up in August of
2003, NeWave has since grown to having serviced over 100,000 individuals,
and is currently generating high margin revenues approaching of $1 million
per month. 100% of the company's growth has come organically- they have
not acquired any existing businesses. Most of their revenues are recurring
subscription fees, which makes for a powerful and profitable business model.
Here's the quarter by quarter track
record, beginning with the 1st quarter of '04:
-
Q1 '04: $1 million
-
Q2 '04: $1.8 million
-
Q3 '04: $2.1 million
On the moderately negative side,
shares of NWAV remain very thinly traded. As you can see, the stock
has traded between $3 and $4.50 for the entire year, without any major
break outs or break downs.
The OTC Journal has covered
a number of thinly traded issues in the past which eventually traded much
higher volumes. NWKI, BPTR, CADA, and HYPD come to mind.
With more volume came price improvement on all these issues.
NWAV is currently in a regulatory
"quiet period" compliments of a registration process with the SEC. Once
the process is completed, I expect the company to be considerably more
vocal with the investing community.
Next year NWAV should focus
on rolling out its eBay drop off location business, using celebrity and
national spokesperson Bob Eubanks to get the word out.
The structure of the registration
statement should not lead to any massive excess supplies of stock. Therefore,
I don't see a lot of technical risk.
Look for NWAV to end up on
many new investors' radar screens in 2005. I expect to continue to cover
this one for quite some time. I believe they have two to three years of
rapid growth out in front of them.
|
|
| The OTCjournal.com Newsletter is
an independent electronic publication committed to providing our readers
with factual information on selected publicly traded companies. All
companies are chosen on the basis of certain financial analysis and other
pertinent criteria with a view toward maximizing the upside potential
for investors while minimizing the downside risk, whenever possible.
Moreover, as detailed below, this publication accepts compensation from
certain of the companies which it features. Likewise, this newsletter
is owned by MarketByte, LLC. To the degrees enumerated herein,
this newsletter should not be regarded as an independent publication.
Go
Here to view our compensation on every company we have ever covered,
or visit the following web address: http://www.otcjournal.com/disclaimer.html
for our full profiles and http://www.otcjournal.com/trading-alerts/disclaimer.html
for Trading Alerts. MarketBtye LLC has been paid of fee of $25,000 in cash
and 250,000 newly issued, restricted shares by NuWave for coverage of the
company.
All statements and expressions are
the sole opinions of the editors and are subject to change without notice.
A profile, description, or other mention of a company in the newsletter
is neither an offer nor solicitation to buy or sell any securities
mentioned. While we believe all sources of information to be factual and
reliable, in no way do we represent or guarantee the accuracy thereof,
nor the statements made herein.
From time to time MarketByte LLC
sells shares in the open market it receives as compensation for coverage
of client companies. Since the shares are received as compensation for
services as previously disclosed, and not for investment purposes, the
editors do not view the sale of the shares as contradictory to any advice
delivered in the content. This should be viewed as a conflict of interest
by shareholders or prospective shareholders of the client companies.
The editor, members of the editor's
family, and/or entities with which they are affiliated aside from MarketBtye
LLC itself, are forbidden by company policy to own, buy, sell or otherwise
trade stock for their own benefit in the companies who appear in the publication
unless specifically disclosed in the newsletter. Some of the companies
featured in the OTC Journal pay a cash ESP fee to an affiliated technology
company ranging from $2,000 to $5,000 per month for internet related technology
services.
The profiles, critiques, and other
editorial content of the OTCjournal.com may contain statements that appear
foward relating to the expected capabilities of the companies mentioned
herein.
THE READER SHOULD VERIFY ALL CLAIMS
AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED.
INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE
OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT
LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY
WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCjournal.com.
We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or
the National Association of Securities Dealers ("NASD") at http://www.nasd.com.
We also strongly recommend that you read the SEC advisory to investors
concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Disclaimer ID:$subst('Recip.userid') Readers can review all public filings
by companies at the SEC's EDGAR page. The NASD has published information
on how to invest carefully at its web site. MarketByte LLC's mailing
address is 3525 Del Mar Heights Rd #334, San Diego, CA 92130.
You
can unsubscribe from this list at any time by
Clicking
Here and HITTING SEND. If you are having difficulty removing
yourself or wish to change your address please go to http://listserv.otcjournal.com/opt.cgi?. |
|
|
|
Click Here to View the OTC Journal Disclosure
|
|
To subscribe to our newsletter, please enter your email address below.
Quotes are delayed 20 minutes.

|